Skip to main content
OpenTrials

Clinical trial condition

Relapsed or Refractory Acute Myeloid Leukemia (AML)

Explore clinical trials studying Relapsed or Refractory Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.

4 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Relapsed or Refractory Acute Myeloid Leukemia (AML) trial results

Recruiting

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

NCT02074839

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic-AZ Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California-Los Angeles Los Angeles, California, United States
View all 30 locations
View Trial Details

Related conditions